Schroder Investment Management Group
EIGR

Schroder Investment Management Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Schroder Investment Management Group’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-19
Closed -$11K – 1238
2015
Q2 		$11K Buy
+19
New +$52.6K ﹤0.01% 1182

Other funds holding EIGR

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Schroder Investment Management Group's EIGR Position: Q3 2015 in Review

Schroder Investment Management Group sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q3 2015, closing a stake of 19 shares — an estimated $11K sold.

Schroder Investment Management Group first reported a position in EIGR in Q2 2015 and held it in 1 quarter. The position peaked at $11K in Q2 2015. 41 funds tracked by Wall St. Rank hold EIGR as of Q3 2015.

  • Schroder Investment Management Group reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Schroder Investment Management Group sold 19 Eiger BioPharmaceuticals, Inc. shares in Q3 2015, an estimated $11K.
  • Schroder Investment Management Group first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2015 and held it in 1 quarter.
  • Schroder Investment Management Group's Eiger BioPharmaceuticals, Inc. position peaked at $11K in Q2 2015.
  • 41 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q3 2015.

Based on Schroder Investment Management Group's 13F filing for Q3 2015, filed 13 Nov 2015.